Skip to main content

Search this site

Eyebrow Menu

Magazine
Photo Galleries
Podcasts
Comparison Charts
Blogs
- Blogs
- Blog Series
Calendar
360 Photos
Case Studies
Buyer's Guide

Search this site

Sign In
New User? Register Here

FDA
COVID-19
Imaging
3-D Printing

Angiography

Computed Tomography (CT)

Contrast media/injectors

Digital Radiography (DR)

Magnetic Resonance Imaging (MRI)

Molecular Imaging

Pediatric Imaging

Radiation dose management

Radiographic Fluoroscopy (RF)

Ultrasound Imaging
Information Technology
Advanced visualization

Analytics Software

Archive/storage

Artificial Intelligence

Clinical decision support

Digital Pathology

Enterprise Imaging

Flat panel displays

Imaging software development

PACS

Population Health

Remote viewing systems

Teleradiology

Vendor neutral archives (VNA)
Women's Health
Breast Biopsy Systems

Breast Density

Breast Imaging

Breast MRI

Ultrasound Women's Health
Radiation Oncology
Oncology information management systems (OIMS)

Patient positioning/immobilization

Proton Therapy

Radiation therapy

Treatment planning software/systems
Video
Webinars
Conference Coverage
AAPM

ACC

ACR

AHRA

AIMed

ARRS

ASTRO

ECR

HIMSS

RSNA

SBI

SCCT

SIIM

SIR

SNMMI

If you enjoy this content, please share it with a colleague

If you enjoy this content, please share it with a colleague

GenomeDx Biosciences

10355 Science Center Drive

Suite 240

San Diego, CA 92121

Phone:

888.975.4540 x101

http://genomedx.com/

RELATED CONTENT

GenomeDx Biosciences, Decipher, prostate cancer, radiation therapy, test

News

Decipher Prostate Cancer Test Found to Predict Benefits of Radiation ...

GenomeDx Biosciences announced the publication of a positive validation study for the Decipher Prostate Cancer Classifier, a genomic test for prostate cancer.

February 27, 2015

© Copyright Wainscot Media. All Rights Reserved.

Bottom Menu

Topics We Cover
Glossary
Advertise
Contact
Privacy Policy
Cookie Policy
Terms and Conditions

Subscribe Now

E-newsletter Subscription form